Stocks and Investing
Stocks and Investing
Tue, October 31, 2017
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, October 30, 2017
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Rahul Jasuja Initiated (ALNY) at Strong Buy and Held Target at $150 on, Oct 30th, 2017
Rahul Jasuja of FBR Capital, Initiated "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy and Held Target at $150 on, Oct 30th, 2017.
Rahul has made no other calls on ALNY in the last 4 months.
There are 8 other peers that have a rating on ALNY. Out of the 8 peers that are also analyzing ALNY, 2 agree with Rahul's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Paul Matteis of "Leerink Swann" Maintained at Hold with Increased Target to $112 on, Thursday, September 21st, 2017
- David Lebovitz of "Morgan Stanley" Maintained at Hold with Increased Target to $101 on, Thursday, September 21st, 2017
These are the ratings of the 6 analyists that currently disagree with Rahul
- Terence Flynn of "Goldman Sachs" Upgraded from Hold to Strong Buy on, Monday, October 2nd, 2017
- Do Kim of "BMO Capital" Maintained at Buy with Increased Target to $134 on, Friday, September 22nd, 2017
- Geoff Meacham of "Barclays" Maintained at Buy with Increased Target to $127 on, Thursday, September 21st, 2017
- Alan Carr of "Needham" Maintained at Strong Buy with Increased Target to $125 on, Thursday, September 21st, 2017
- Alethia Young of "Credit Suisse" Maintained at Buy with Increased Target to $123 on, Thursday, September 21st, 2017
- Christopher Marai of "Nomura" Initiated at Sell and Held Target at $56 on, Friday, September 15th, 2017